Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/络泰

Approved

中药

络泰

昆药集团股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Aug 12, 2020
Approval ID: 7LeaeRh5pOd
Company: 昆药集团股份有限公司
Type: 中药

Approval Details

Approval Id: 7LeaeRh5pOd
Approval Number: 国药准字Z53020662
Generic Name: 血塞通注射液
Brand Name: 络泰
Drug Type: 中药
Dosage Form: 注射剂
Strength: 10ml:250mg
Reg Date: 2020-08-12
Company Name: 昆药集团股份有限公司
Production Company Name: 昆药集团股份有限公司
Production Company Address: 云南省昆明市西郊七公里
Company Detail Path: /organization/kpc-pharmaceuticals-inc
Production Company Detail Path: /organization/kpc-pharmaceuticals-inc

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 12, 2020

Approval ID

7LeaeRh5pOd

Type

中药

Back to NMPA Approvals

络泰 - NMPA Drug Approval Details